Editas Medicine
Jieni Xu is the Head of Delivery Science at Editas Medicine since September 2024, previously serving as Principal Scientist and Senior Scientist at Kernal Biologics from April 2021 to September 2024. Before that, Jieni Xu worked as a Senior Research Scientist at Phosphorex, focusing on polymeric and lipid nanoparticle formulations for nucleic acids and gene therapy. Jieni Xu's academic background includes a Ph.D. in Pharmaceutical Sciences from the University of Pittsburgh, where extensive research involved designing cationic polymeric nanocarriers for gene delivery. An MBA in Health Sector Management was obtained from Boston University, featuring education in pharmacy from Shenyang Pharmaceutical University.
This person is not in any teams
Editas Medicine
5 followers
Editas Medicine is a leading genome editing company focused on translating the power and promise of our proprietary genome editing systems into medicines to help transform the lives of people with genetically-defined diseases. Their goal is to discover, develop, manufacture, and commercialize transformative medicines for a range of serious diseases, including eye diseases, blood diseases, and cancer.